CUSIP 20454B104COMCMPXQ4 2025
40 filings · latest Feb 13, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Tang Capital Management LLC | 16.79M | $90.17M |
| 2 | Orbimed Advisors LLC | 15.22M | $81.73M |
| 3 | Suvretta Capital Management, LLC | 14.18M | $76.16M |
| 4 | Vivo Capital, LLC | 9.55M | $51.26M |
| 5 | Blackrock, Inc. | 9.39M | $50.42M |
| 6 | Vanguard Group Inc | 8.05M | $43.22M |
| 7 | Enavate Sciences Gp, LLC | 7.79M | $41.82M |
| 8 | Bvf Inc/Il | 7.76M | $41.70M |
| 9 |
| 4 | Nov 14, 2025 | Tang Capital Management, LLC | 13G/A | 10.0% | 17.18M | SEC |
| 5 | Nov 14, 2025 | Vivo Opportunity Fund Holdings, L.P. | 13G | 5.1% | 9.00M | SEC |
| 6 | Oct 29, 2025 | Biotechnology Value Fund L P | 13G | 5.1% | 8.75M | SEC |
| 7 | Aug 21, 2025 | Suvretta Capital Management, LLC | 13G/A | 8.2% | 14.10M | SEC |
| 8 | Aug 18, 2025 | Commander Aggregator, LP | 13D/A | 4.5% | — | SEC |
| 9 | Aug 15, 2025 | Orbimed Advisors LLC | 13D/A | 8.9% | — | SEC |
| 10 | Aug 14, 2025 | Tang Capital Management, LLC | 13G/A | 9.8% | 13.50M | SEC |
See the full Schedule 13D/13G history for Compass Therapeutics Inc.
Unlock full history| 6.13M |
| $32.90M |
| 10 | State Street Corp | 4.89M | $26.26M |